Matthew Maxwell Donley, EVP, Global HR, IT & Strategy at Sucampo Pharmaceuticals, holds 584.07K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 36.98K shares in Sucampo Pharmaceuticals (Ticker: SCMP). Most recently, Matthew Maxwell Donley Sold ― shares of Aurinia Pharmaceuticals on Mar 07, 2024 for an estimated value of 224.06K.